Non-immune hydrops fetalis: genes and variants
Explore variant evidence for Non-immune hydrops fetalis across 3 analyzed proteins (PIEZO1, HRAS, PTPN11). Linked ClinVar records include 4 pathogenic or likely pathogenic variants, 1 variants of uncertain significance and 2 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-21. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Non-immune hydrops fetalis
PIEZO1: Piezo-type mechanosensitive ion channel component 1
The protein forms a mechanically activated, nonselective cation channel that converts membrane tension into an electrical and calcium signal. It contributes to touch, blood-cell volume control, and lymphatic development, and PIEZO1 variants are associated with dehydrated stomatocytosis and lymphatic malformations.
2 ClinVar pathogenic / likely pathogenic and 2 uncertain variants in PIEZO1 have source records linked to Non-immune hydrops fetalis. Association strength is not clinical gene validity.
HRAS: GTPase HRas
Its GTP-bound state activates RAF-MEK-ERK and other pathways downstream of growth-factor receptors. Somatic activating variants drive several cancers, while germline activating variants cause Costello syndrome.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in HRAS have source records linked to Non-immune hydrops fetalis. Association strength is not clinical gene validity.
PTPN11: Tyrosine-protein phosphatase non-receptor type 11
Its SHP2 phosphatase activity promotes RAS-MAPK signaling downstream of many receptor tyrosine kinases and cytokine receptors. Germline dysregulating variants cause Noonan-spectrum disorders, while somatic activating variants drive juvenile myelomonocytic leukemia and other cancers.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in PTPN11 have source records linked to Non-immune hydrops fetalis. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): RIT1, KRAS and NSD1.
ClinVar pathogenic and likely pathogenic variants linked to Non-immune hydrops fetalis
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| HRAS G13R | 13 | Pathogenic / likely pathogenic (★★) | |
| PIEZO1 R2456H | 2456 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| PIEZO1 V598M | 598 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| PTPN11 T507K | 507 | Tyrosine-protein phosphatase | Pathogenic / likely pathogenic (★★) |
Same protein, different disease
- Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema also has ClinVar records linked to PIEZO1 variants; they fall mostly in different places as the Non-immune hydrops fetalis variants (12 pathogenic / likely pathogenic).
- Lymphatic malformation also has ClinVar records linked to PIEZO1 variants; they fall mostly in different places as the Non-immune hydrops fetalis variants (6 pathogenic / likely pathogenic).
- Costello syndrome also has ClinVar records linked to HRAS variants; they fall mostly in different places as the Non-immune hydrops fetalis variants (15 pathogenic / likely pathogenic).
- RASopathy also has ClinVar records linked to HRAS variants; they fall mostly in different places as the Non-immune hydrops fetalis variants (6 pathogenic / likely pathogenic).
- Large congenital melanocytic nevus also has ClinVar records linked to HRAS variants; they fall partly in the same places as the Non-immune hydrops fetalis variants (5 pathogenic / likely pathogenic).
- Thyroid cancer, nonmedullary also has ClinVar records linked to HRAS variants; they fall partly in the same places as the Non-immune hydrops fetalis variants (3 pathogenic / likely pathogenic).
- RASopathy also has ClinVar records linked to PTPN11 variants; they fall mostly in different places as the Non-immune hydrops fetalis variants (51 pathogenic / likely pathogenic).
- Noonan syndrome also has ClinVar records linked to PTPN11 variants; they fall mostly in different places as the Non-immune hydrops fetalis variants (44 pathogenic / likely pathogenic).
- Noonan syndrome and Noonan-related syndrome also has ClinVar records linked to PTPN11 variants; they fall mostly in different places as the Non-immune hydrops fetalis variants (29 pathogenic / likely pathogenic).
- LEOPARD syndrome also has ClinVar records linked to PTPN11 variants; they fall mostly in different places as the Non-immune hydrops fetalis variants (16 pathogenic / likely pathogenic).
- Metachondromatosis also has ClinVar records linked to PTPN11 variants; they fall mostly in different places as the Non-immune hydrops fetalis variants (11 pathogenic / likely pathogenic).
Diseases related to Non-immune hydrops fetalis
- RASopathy, also linked to HRAS and PTPN11
- Noonan syndrome, also linked to HRAS and PTPN11
- Noonan syndrome and Noonan-related syndrome, also linked to HRAS and PTPN11
- Hypertrophic cardiomyopathy, also linked to HRAS
- Acute myeloid leukemia, also linked to PTPN11
- LEOPARD syndrome, also linked to PTPN11
- Urinary bladder cancer, also linked to HRAS
- Costello syndrome, also linked to HRAS
- Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema, also linked to PIEZO1
- Heart disease, also linked to PTPN11
- Metachondromatosis, also linked to PTPN11
- Myelomonocytic leukemia, also linked to PTPN11
Frequently asked questions
Which genes have records linked to Non-immune hydrops fetalis?
This view contains 3 analyzed proteins: PIEZO1, HRAS, PTPN11. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 4 pathogenic or likely pathogenic variants, 1 variants of uncertain significance and 2 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 13 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center